Abeona Therapeutics Announces Closing of $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Abeona Therapeutics Inc. (Nasdaq: ABEO) has successfully completed a registered direct offering, raising an impressive $25 million in gross proceeds. What's even more remarkable is that this offering was carried out without any discounts or warrant coverage, highlighting the unwavering confidence of existing institutional investors in Abeona. The purpose behind this fundraising success is to pre..